...
首页> 外文期刊>Asian journal of surgery >Comparison of topical isosorbide mononitrate, topical diltiazem, and their combination in the treatment of chronic anal fissure
【24h】

Comparison of topical isosorbide mononitrate, topical diltiazem, and their combination in the treatment of chronic anal fissure

机译:局部硝酸异山梨酯,局部地尔硫卓及其组合治疗慢性肛裂的比较

获取原文

摘要

Summary Background/Objective Chronic anal fissure is a painful condition that is associated with an increase in internal anal sphincter pressure. The main aim of this study is to evaluate the efficacy and adverse effects of topical isosorbide 5 mononitrate and topical diltiazem, when administered either as single agents or in combination, in the treatment of anal fissure. Methods Patients with chronic anal fissure were enrolled in the study. They were randomized into three groups: Group A (0.2% isosorbide 5 mononitrate users), Group B (2% diltiazem users), and Group C (2%diltiazem?+?0.2% isosorbide 5 mononitrate users). Pain was evaluated using a visual analog scale (VAS). Level of strain during defecation was graded on a 4-point scale. Results A total of 55 patients were enrolled in the study. The average ages of patients in Groups A, B, and C were 37.94?±?16.19, 42.83?±?13.21, 40?±?13.58 years, respectively. After treatment, pain completely abated in 55.6% of patients in Group A, 27.8% ( n ?=?5) in Group B, and 42.1% ( n ?=?8) in Group C. The decreases in average VAS values prior to and after treatment in Groups A, B, and C were statistically significant ( p values 0.0001, 0.001, and 0.0001, respectively). Average strain scores prior to and after treatment were 2.11/0.72 for Group A, 2.17/0.94 for Group B, and 1.95/0.47 for Group C. Strain during defecation prior to and after treatment in Groups A, B, and C was statistically significant ( p values 0.001, 0.001, and 0.003, respectively). Conclusion Topical diltiazem and a combination of nitrate and diltiazem can be used in the treatment of anal fissure. However, the agents are not significantly superior each other.
机译:发明背景/客观的慢性肛裂是一种痛苦的状况,与内部肛门括约肌压力的增加有关。这项研究的主要目的是评估当单剂或联合使用时,局部硝酸异山梨酯5单硝酸盐和局部地尔硫卓的疗效和不良反应在治疗肛裂中的作用和不良反应。方法将慢性肛裂患者纳入研究。他们被随机分为三组:A组(0.2%异山梨醇5单硝酸盐使用者),B组(2%地尔硫卓使用者)和C组(2%地尔硫ze + 0.2%异山梨醇5单硝酸盐使用者)。使用视觉模拟量表(VAS)评估疼痛。排便时的应变水平以4分制进行分级。结果共有55例患者入选该研究。 A,B和C组的患者平均年龄分别为37.94±±16.19岁,42.83±±13.21岁,40±±13.58岁。治疗后,A组55.6%的患者,B组27.8%(n?=?5)和C组42.1%(n?=?8)的患者疼痛得到完全减轻。 A组,B组和C组的治疗后和经统计学处理后具有统计学意义(p值分别为0.0001、0.001和0.0001)。 A组在治疗前后的平均应变评分为2.11 / 0.72,B组为2.17 / 0.94,C组为1.95 /0.47。A,B和C组在治疗前后排便期间的应变具有统计学意义(p分别为0.001、0.001和0.003)。结论局部地尔硫卓和硝酸盐与地尔硫卓联用可治疗肛裂。但是,这些代理之间并没有明显的优势。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号